Targeting immunometabolism to treat COVID-19

The COVID-19 crisis has emphasised the need for antiviral therapies to combat current and future viral zoonoses. Recent studies have shown that immune cells such as macrophages are the main contributors to the inflammatory response seen in the later inflammatory phase of COVID-19. Immune cells in th...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Carroll, Shane M, O’Neill, Luke A J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Targeting Immunometabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195165/
https://www.ncbi.nlm.nih.gov/pubmed/34240083
http://dx.doi.org/10.1093/immadv/ltab013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195165/
https://www.ncbi.nlm.nih.gov/pubmed/34240083
http://dx.doi.org/10.1093/immadv/ltab013

Ejemplares similares